Clinical trial recruitment is one of the most persistent and costly challenges in drug development. Researchers typically recruit from within their own clinical practices, with little ability to reach beyond their patient populations. The process of reviewing charts, assessing eligibility, and screening participants is time-consuming and expensive. Patients are equally challenged: most have poor awareness of clinical trials or where to find them, and those not receiving care from a trial investigator are invisible to researchers, even when they may be ideal candidates. The financial cost of these gaps is significant. As many as 86% of trials fail to meet recruitment targets on time [1], with each day of delay in drug development costing up to $500,000 [2]. Of the 57% of clinical trials that terminate early, the biggest factor is the inability to meet recruitment targets [3]. We Search Research (WSR) seeks to address the challenges faced by researchers and patients and accelerate recruitment to clinical trials. By utilizing WSR’s innovative AI-powered platform, anyone can find a clinical trial, screen themselves against study participation criteria, and be conveniently connected to the closest researcher enrolling participants. By delivering pre-screened potential participants through the platform, researchers save time and gain access to individuals that may have been invisible to them. Pre-screening also allows staff to re-allocate their time to other study- related activities, delivering cost savings. Huang GD, et al., Contemp Clin Trials. 2018;66:74–9. Smith ZP, et al., Ther Innov Regul Sci. 2024;58(5):855–62. Speich B, et al., JAMA Network Open. 2025.